Technically speaking, bioavailability is the amount of a molecule or chemical that is readily available in the bloodstream. In terms of the consumption of CBG and CBD products, bioavailability features three stages: Onset, peak, and duration. Onset is the length of time required for the molecule to begin having an effect on the consumer. Peak is when the effects of a molecule or chemical are greatest, often in the middle of its overall duration. Duration is the total length of effect of a molecule. Different paths of consumption result in vastly different bioavailability.
CBGA, the acidic precursor to cannabigerol (CBG), is the genesis of many major cannabinoids derived from cannabis – including cannabidiol (CBD) and tetrahydrocannabinol (THC). The
Cannabinoids exist not in a single state, but rather multiple versions go a source molecule called an acidic precursor. These variants are called analogs. This
The endocannabinoid system is populated by millions of specialized cellular receptors that bind perfectly with both endocannabinoids (such as anandamide and 2-AG) and the phytocannabinoids
Technically speaking, bioavailability is the amount of a molecule or chemical that is readily available in the bloodstream. In terms of the consumption of CBG
What’s a Cannabinoid? Simply speaking, cannabinoids are molecules that exist naturally in both the human body and cannabis plants. Cannabinoids from cannabis are called phytocannabinoids
You’ve probably heard of popular chemotypes like Sativa and Indica, or the lesser-known Ruderalis, but did you know scientists have discovered a possible 4th chemotype?
